Brief: Vtv Therapeutics Announces 2023 First Quarter Financial Results And Provides Corporate Update
11/05/2023 22:10
vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES 2023 FIRST QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* VTV THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.06
* VTV THERAPEUTICS INC Q1 LOSS PER SHARE $0.06
Source text for Eikon: ID:nGNXbHc8fj
Further company coverage: VTVT.O
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)